Original Research Article I Volume 4 I Issue 1 I 2016

Assessment of hemodialysis adequacy in patients with helicobacter pylori infection before and after eradication therapy

Nashwa Sabry Bakr; Eman Ezzat El-Gohary; Nany Hassan El-Gaiar

Biolife; 4(1), pp 100-106

DOI:https://doi.org/10.5281/zenodo.7312523

Abstract:

Background: Helicobacter pylori has notable relationship with hemodialysis. H. pylori infection is a major risk factor for gastrointestinal troubles in dialysis patients. All hemodialysis patients should have regular assessment of dialysis adequacy. For the adequacy of hemodialysis, Urea reduction ratio (URR) and Kt/V are commonly used. Nashwa Sabry

Keywords:

Helicobacter pylori, Hemodialysis, Dialysis Adequacy, Urea reduction ratio, URR, Kt/V.

References:

  1. Sugimoto M, Sakai K, Kita M, Imanishi J, Yamaoka Y. Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int 2009;75:96-103.
  2. Sugimoto M, Yamaoka Y. Review of Helicobacter pylori infection and chronic renal failure. Ther Apher Dial 2011;15:1-9.
  3. Sotoudehmanesh R, Ali Asgari A, Ansari R, Nouraie M. Endoscopic findings in end-stage renal disease. Endoscopy 2003;35:502-5.
  4. Khedmat H, Ahmadzad-Asl M, Amini M, Lessan-Pezeshki M, Einollahi B, Pourfarziani V, et al. Gastro-duodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients. Transplant Proc 2007;39:1003-7.
  5. Sezer S, Ibis A, Ozdemir BH, Ozdemir FN, Kulah E, Boyacioglu S, et al. Association of helicobacter pylori infection with nutritional status in hemodialysis patients. Transplant Proc 2004;36:47-9.
  6. Nakajima F, Sakaguchi M, Amemoto K, Oka H, Kubo M, Shibahara N, et al. Helicobacter pylori in patients receiving long-term dialysis. Am J Nephrol 2002;22:468-72.
  7. Fabbian F, Catalano C, Bordin V, Balbi T, Di Landro D. Esophagogastroduodenoscopy in chronic hemodialysis patients: 2-year clinical experience in a renal unit. Clin Nephrol 2002;58:54-9.
  8. Lentine KL, Parsonnet J, Taylor I, Wrone EM, Lafayette RA. Associations of serologic markers of infection and inflammation with vascular disease events and mortality in American dialysis patients. Clin Exp Nephrol 2006;10:55-62.
  9. Gioe FP, Cudia B, Romano G, Cocchiara G, Li Vecchi V, Gioe MA, et al. Role and clinical importance of Helicobacter pylori infection in hemodialysis patients. G Chir 2008;29:81-4.
  10. Nakajima F, Sakaguchi M, Oka H, Kawase Y, Shibahara N, Inoue T, et al. Prevalence of Helicobacter pylori antibodies in long-term dialysis patients. Nephrology (Carlton) 2004;9:73-6.
  11. Bauerfeind P, Garner R, Dunn BE, Mobley HL. Synthesis and activity of Helicobacter pylori urease and catalase at low pH. Gut 1997;40:25-30.
  12. Montecucco C, Rappuoli R. Living dangerously: how Helicobacter pylori survives in the human stomach. Nat Rev Mol Cell Biol 2001;2:457-66...

Article Dates:

Received: 6 January 2016; Accepted: 22 February 2016; Published: 4 March 2016

How To Cite:

Nashwa Sabry Bakr, Eman Ezzat El-Gohary, & Nany Hassan El-Gaiar. (2022). Assessment of hemodialysis adequacy in patients with helicobacter pylori infection before and after eradication therapy. Biolife, 4(1), 100–106. https://doi.org/10.5281/zenodo.7312523

Download Full Paper: PDF
Submit Manuscript
Join as Reviewer / Editor

Logo


Logo